CD45-targeted PET enables the visualization of inflammatory conditions.

IF 2 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

American journal of nuclear medicine and molecular imaging Pub Date : 2025-06-25 eCollection Date: 2025-01-01 DOI:10.62347/VFWR2835

Chongjiao Li, Zhendong Song, Qilong Hu, Yinlong Li, Jimmy S Patel, Steven H Liang

引用次数: 0

Abstract

Inflammation is a major contributor to human mortality, accounting for over 50% of deaths worldwide. Therefore, there is an urgent need for early and accurate diagnostic methods. PET imaging targeting leukocyte common antigen CD45 presents a promising approach for detecting inflammation and monitoring therapeutic responses.

查看原文本刊更多论文

靶向cd45的PET能够可视化炎症状况。

炎症是人类死亡的一个主要原因，占全世界死亡人数的50%以上。因此，迫切需要早期准确的诊断方法。针对白细胞共同抗原CD45的PET成像为检测炎症和监测治疗反应提供了一种很有前途的方法。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

American journal of nuclear medicine and molecular imaging RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING-

自引率

4.00%

发文量

期刊介绍： The scope of AJNMMI encompasses all areas of molecular imaging, including but not limited to: positron emission tomography (PET), single-photon emission computed tomography (SPECT), molecular magnetic resonance imaging, magnetic resonance spectroscopy, optical bioluminescence, optical fluorescence, targeted ultrasound, photoacoustic imaging, etc. AJNMMI welcomes original and review articles on both clinical investigation and preclinical research. Occasionally, special topic issues, short communications, editorials, and invited perspectives will also be published. Manuscripts, including figures and tables, must be original and not under consideration by another journal.